glp-1 venus williams glp 1 SerenaWilliams is opening up about her experience with the drug Serena Williams talks GLP-1 weight

Diabetes Obesity & Metabolism 15 , 1527, doi:10.1111/j.1463-1326.2012.01663.x (2013)

Existing GLP1R agonists come with boxed warnings of thyroid cancer and pancreatitis, based mainly on rodent studies, where the effects of GLP1R agonism have noted species differences (For example, weight loss in rodents is mainly due to increased energy expenditure, whereas in humans it occurs via less food intake [54] )

BMC Health Services Research 12(1):1

Moreover, LPS treatment upregulated nuclear NF-b p65 (pS536) protein levels, while exendin-4 reduced nuclear NF-B p65 (pS536) levels, suggesting that GLP-1 analogs may modulate inflammatory cytokine expression by interfering with NF-B p65 phosphorylation and translocation to the nucleus (Figure 7)